(-)-demecolcine increases expression ISO RGD:1349362 6480464 Demecolcine results in increased expression of CYP4F3 mRNA CTD PMID:23649840 (S)-nicotine increases expression ISO RGD:1349362 6480464 Nicotine results in increased expression of CYP4F3 mRNA CTD PMID:23825647 1,1-dichloroethene increases expression ISO RGD:1313186 6480464 vinylidene chloride results in increased expression of CYP4F18 mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:1313186 6480464 ethylene dichloride results in increased expression of CYP4F18 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1313186 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CYP4F18 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1313186 6480464 1, 2-Dimethylhydrazine results in increased expression of CYP4F18 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1349362 6480464 Estradiol results in decreased expression of CYP4F3 mRNA CTD PMID:17982697 17beta-estradiol multiple interactions ISO RGD:1349362 6480464 [Parathion co-treated with Estradiol] results in increased expression of CYP4F3 mRNA CTD PMID:17982697 19(S)-HETE increases chemical synthesis ISO RGD:1349362 6480464 CYP4F3 protein alternative form results in increased chemical synthesis of 19-hydroxy-5 more ... CTD PMID:30259074 19-HETE increases chemical synthesis ISO RGD:1349362 6480464 CYP4F3 protein alternative form results in increased chemical synthesis of 19-hydroxy-5 more ... CTD PMID:30259074 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313186 6480464 Tetrachlorodibenzodioxin affects the expression of CYP4F18 mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP4F18 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313186 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP4F18 mRNA CTD PMID:28213091 20-HETE increases chemical synthesis ISO RGD:1349362 6480464 CYP4F3 protein alternative form results in increased chemical synthesis of 20-hydroxy-5 more ... CTD PMID:30259074 3,4-dichloroaniline increases expression ISO RGD:1349362 6480464 3, 4-dichloroaniline results in increased expression of CYP4F3 mRNA CTD PMID:24172598 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP4F18 mRNA CTD PMID:24780913 all-trans-retinoic acid increases expression ISO RGD:1349362 6480464 Tretinoin results in increased expression of CYP4F3 mRNA, Tretinoin results in increased expression of CYP4F3 protein CTD PMID:17218384 more ... amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of CYP4F18 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1349362 6480464 Antirheumatic Agents results in decreased expression of CYP4F3 mRNA CTD PMID:24449571 arachidonic acid multiple interactions ISO RGD:1349362 6480464 rubiarbonone C inhibits the reaction [CYP4F3 protein alternative form results in increased hydroxylation of Arachidonic Acid] CTD PMID:30259074 arachidonic acid increases hydroxylation ISO RGD:1349362 6480464 CYP4F3 protein alternative form results in increased hydroxylation of Arachidonic Acid CTD PMID:30259074 benzene increases expression ISO RGD:1349362 6480464 Benzene results in increased expression of CYP4F3 mRNA, Benzene results in increased expression of CYP4F3 protein CTD PMID:20036648 benzene increases expression ISO RGD:1313186 6480464 Benzene metabolite results in increased expression of CYP4F18 mRNA CTD PMID:23940708 benzo[a]pyrene decreases expression ISO RGD:1313186 6480464 Benzo(a)pyrene results in decreased expression of CYP4F18 mRNA CTD PMID:20127859 benzo[a]pyrene decreases expression ISO RGD:1349362 6480464 Benzo(a)pyrene results in decreased expression of CYP4F3 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:1349362 6480464 Benzo(a)pyrene results in decreased methylation of CYP4F3 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1313186 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CYP4F18 mRNA] CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1313186 6480464 Benzo(a)pyrene results in increased expression of CYP4F18 mRNA CTD PMID:22228805 beta-naphthoflavone increases expression ISO RGD:1349362 6480464 beta-Naphthoflavone results in increased expression of CYP4F3 mRNA CTD PMID:28601433 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP4F3 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:1349362 6480464 bisphenol A affects the expression of CYP4F3 mRNA CTD PMID:30903817 buta-1,3-diene decreases expression ISO RGD:1313186 6480464 1, 3-butadiene results in decreased expression of CYP4F18 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:1349362 6480464 butyraldehyde results in decreased expression of CYP4F3 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:1349362 6480464 Cadmium results in increased expression of CYP4F3 mRNA CTD PMID:21120746 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of CYP4F18 promoter CTD PMID:22457795 carbamazepine increases expression ISO RGD:1349362 6480464 Carbamazepine results in increased expression of CYP4F3 mRNA CTD PMID:17112801 carbon nanotube increases expression ISO RGD:1313186 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:27106021 chloroprene decreases expression ISO RGD:1313186 6480464 Chloroprene results in decreased expression of CYP4F18 mRNA CTD PMID:23125180 chromium(6+) affects expression ISO RGD:1313186 6480464 chromium hexavalent ion affects the expression of CYP4F18 mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:1349362 6480464 Cisplatin results in increased expression of CYP4F3 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1349362 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CYP4F3 mRNA CTD PMID:27392435 copper(II) sulfate decreases expression ISO RGD:1349362 6480464 Copper Sulfate results in decreased expression of CYP4F3 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1349362 6480464 Asbestos, Crocidolite results in decreased expression of CYP4F3 mRNA CTD PMID:18687144 , PMID:25351596 deoxynivalenol multiple interactions ISO RGD:1349362 6480464 [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CYP4F3 mRNA, [deoxynivalenol co-treated with Zearalenone] results in increased expression of CYP4F3 mRNA CTD PMID:28865950 , PMID:28935499 dimethylarsinic acid multiple interactions ISO RGD:1313186 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA CTD PMID:34876320 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CYP4F18 mRNA CTD PMID:33729688 diuron increases expression ISO RGD:1349362 6480464 Diuron metabolite results in increased expression of CYP4F3 mRNA CTD PMID:24172598 ethanol multiple interactions ISO RGD:1313186 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYP4F18 mRNA CTD PMID:30517762 ethyl methanesulfonate increases expression ISO RGD:1349362 6480464 Ethyl Methanesulfonate results in increased expression of CYP4F3 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:1313186 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CYP4F18 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1349362 6480464 Formaldehyde results in increased expression of CYP4F3 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:1349362 6480464 Formaldehyde results in decreased expression of CYP4F3 mRNA CTD PMID:28937961 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYP4F18 mRNA CTD PMID:33387578 Heliotrine decreases expression ISO RGD:1349362 6480464 heliotrine results in decreased expression of CYP4F3 mRNA CTD PMID:26100227 hydroquinone increases expression ISO RGD:1313186 6480464 hydroquinone results in increased expression of CYP4F18 mRNA, hydroquinone results in increased expression of CYP4F18 protein CTD PMID:23940708 isotretinoin decreases expression ISO RGD:1349362 6480464 Isotretinoin results in decreased expression of CYP4F3 mRNA CTD PMID:20436886 mercury dichloride increases expression ISO RGD:1313186 6480464 Mercuric Chloride results in increased expression of CYP4F18 mRNA CTD PMID:24472606 methotrexate increases expression ISO RGD:1349362 6480464 Methotrexate results in increased expression of CYP4F3 mRNA CTD PMID:17400583 methyl methanesulfonate increases expression ISO RGD:1349362 6480464 Methyl Methanesulfonate results in increased expression of CYP4F3 mRNA CTD PMID:23649840 methylarsonic acid multiple interactions ISO RGD:1313186 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA CTD PMID:34876320 nicotine increases expression ISO RGD:1349362 6480464 Nicotine results in increased expression of CYP4F3 mRNA CTD PMID:23825647 obeticholic acid decreases expression ISO RGD:1349362 6480464 obeticholic acid results in decreased expression of CYP4F3 mRNA CTD PMID:27939613 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of CYP4F18 mRNA CTD PMID:30316929 paracetamol affects expression ISO RGD:1313186 6480464 Acetaminophen affects the expression of CYP4F18 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1349362 6480464 Acetaminophen results in increased expression of CYP4F3 mRNA CTD PMID:22230336 parathion increases expression ISO RGD:1349362 6480464 Parathion results in increased expression of CYP4F3 mRNA CTD PMID:17982697 parathion multiple interactions ISO RGD:1349362 6480464 [Parathion co-treated with Estradiol] results in increased expression of CYP4F3 mRNA CTD PMID:17982697 phenobarbital affects expression ISO RGD:1349362 6480464 Phenobarbital affects the expression of CYP4F3 mRNA CTD PMID:19084549 phenol increases expression ISO RGD:1349362 6480464 Phenol results in increased expression of CYP4F3 mRNA, Phenol results in increased expression of CYP4F3 protein CTD PMID:19029204 , PMID:20036648 pirinixic acid decreases expression ISO RGD:1313186 6480464 pirinixic acid results in decreased expression of CYP4F18 mRNA CTD PMID:23811191 rubiarbonone C multiple interactions ISO RGD:1349362 6480464 rubiarbonone C inhibits the reaction [CYP4F3 protein alternative form results in increased hydroxylation of Arachidonic Acid] CTD PMID:30259074 rubiarbonone C decreases activity ISO RGD:1349362 6480464 rubiarbonone C results in decreased activity of CYP4F3 protein alternative form CTD PMID:30259074 Senkirkine decreases expression ISO RGD:1349362 6480464 senkirkine results in decreased expression of CYP4F3 mRNA CTD PMID:26100227 silicon dioxide decreases expression ISO RGD:1349362 6480464 Silicon Dioxide results in decreased expression of CYP4F3 mRNA CTD PMID:25351596 sodium arsenate multiple interactions ISO RGD:1313186 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:1313186 6480464 sodium arsenite results in increased expression of CYP4F18 mRNA CTD PMID:25065748 sodium arsenite multiple interactions ISO RGD:1313186 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:1349362 6480464 sodium arsenite results in decreased expression of CYP4F3 mRNA CTD PMID:29301061 sodium dichromate decreases expression ISO RGD:1313186 6480464 sodium bichromate results in decreased expression of CYP4F18 mRNA CTD PMID:22155349 sulforaphane increases expression ISO RGD:1349362 6480464 sulforaphane results in increased expression of CYP4F3 mRNA CTD PMID:26833863 , PMID:31838189 tetrachloromethane multiple interactions ISO RGD:1313186 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYP4F18 mRNA CTD PMID:30517762 tetracycline increases expression ISO RGD:1313186 6480464 Tetracycline results in increased expression of CYP4F18 mRNA CTD PMID:16917069 thapsigargin decreases expression ISO RGD:1349362 6480464 Thapsigargin results in decreased expression of CYP4F3 mRNA CTD PMID:19442820 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CYP4F18 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1313186 6480464 titanium dioxide results in increased expression of CYP4F18 mRNA CTD PMID:23131501 triptonide increases expression ISO RGD:1313186 6480464 triptonide results in increased expression of CYP4F18 mRNA CTD PMID:33045310 urethane affects expression ISO RGD:1349362 6480464 Urethane affects the expression of CYP4F3 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1349362 6480464 Valproic Acid results in decreased expression of CYP4F3 mRNA CTD PMID:29501571 vincristine increases expression ISO RGD:1349362 6480464 Vincristine results in increased expression of CYP4F3 mRNA CTD PMID:23649840 XL147 multiple interactions ISO RGD:1313186 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CYP4F18 mRNA CTD PMID:27935865 zearalenone multiple interactions ISO RGD:1349362 6480464 [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CYP4F3 mRNA, [deoxynivalenol co-treated with Zearalenone] results in increased expression of CYP4F3 mRNA CTD PMID:28865950 , PMID:28935499 zearalenone decreases expression ISO RGD:1349362 6480464 Zearalenone results in decreased expression of CYP4F3 mRNA CTD PMID:28865950